NCT02164162 Efficacy of a Robotic-assisted Gait Training in Addition to a Conventional Physical Therapy in Parkinson's Disease Status UNKNOWN Phase NA
NCT02162979 Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease Status TERMINATED Phase PHASE2
NCT02157714 Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT02153645 Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. Status TERMINATED Phase PHASE3
NCT02153632 Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID Status TERMINATED Phase PHASE3
NCT02152319 Automated Telehealth Diagnostics for Remote Parkinson Monitoring Status COMPLETED Phase NA
NCT02136914 ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study) Status COMPLETED Phase PHASE3
NCT02134795 A Pilot Study of a Non-Invasive Neuromodulation Device for Treatment of Parkinson's Disease Status TERMINATED Phase NA
NCT02125825 Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration Status COMPLETED Phase N/A
NCT02125383 ParkinStim: Transcranial Direct Current Stimulation for Parkinson's Disease Status COMPLETED Phase NA
NCT02118805 Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders Status COMPLETED Phase N/A
NCT02104401 Open Label Treatment With tDCS for Parkinson's and Related Disorders for Improvement of Speech, Gait and Mood Status COMPLETED Phase PHASE1
NCT02103465 Possible Use of Rotigotine in Subjects 70 Years and Older With Late Onset of Disease Status TERMINATED Phase PHASE2
NCT02101528 Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic Dynamometer Status COMPLETED Phase N/A
NCT02101190 Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment Status COMPLETED Phase PHASE1